Uric acid induces oxidative stress via an activation of the renin–angiotensin system in 3T3-L1 adipocytes

• Published in: Endocrine Vol. 48; no. 1; pp. 135 - 142
• Main Authors: Zhang, Jun-xia, Zhang, Yu-ping, Wu, Qi-nan, Chen, Bing
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.02.2015
• Subjects: 3T3-L1 Cells; Adipocytes - drug effects; Angiotensin II - metabolism; Angiotensin II Type 1 Receptor Blockers - pharmacology; Angiotensin-Converting Enzyme Inhibitors - pharmacology; Angiotensinogen - metabolism; Animals; Antioxidants - pharmacology; Captopril - pharmacology; Cardiovascular Diseases - physiopathology; Diabetes; Endocrinology; Humanities and Social Sciences; Internal Medicine; Medicine; Medicine & Public Health; Mice; multidisciplinary; Original Article; Oxidative Stress - drug effects; Reactive Oxygen Species - metabolism; Renin-Angiotensin System - drug effects; Science; Uric Acid - pharmacology; Renin–angiotensin system; Oxidative stress; Uric acid; Adipocytes
• ISSN: 1355-008X; 1559-0100
• DOI: 10.1007/s12020-014-0239-5

Hyperuricemia is recently reported involving in various obesity-related cardiovascular disorders, especially hypertension. However, the underlying mechanisms are not completely understood. In the present study, we investigated whether uric acid upregulates renin–angiotensin system (RAS) expression in adipocytes. We also examined whether RAS activation plays a role in uric acid-induced oxidative stress in adipocytes. The adipocytes of different phenotypes were incubated with uric acid for 48 h, respectively. Losartan (10 −4  M) or captopril (10 −4  M) was used to block adipose tissue RAS activation. mRNA expressions of angiotensinogen (AGT), angiotensin-converting enzyme-1 (ACE-1), renin, angiotensin type 1 receptor (AT1R), and angiotensin type 2 receptor (AT2R) were evaluated with real-time PCR. Angiotensin II concentrations in supernatant were measured by ELISA. Intracellular reactive species (ROS) levels were measured by fluorescent probe DCFH-DA, DHR, or NBT assay. The uric acid upregulated both RAS (AGT, ACE1, renin, AT1R, and AT2R) mRNA expressions and angiotensin II protein secretion and caused a significant increase in ROS production in 3T3-L1 adipocytes. These effects could be prevented by RAS inhibitors, either losartan or captopril. RAS activation has been causally implicated in oxidative stress induced by uric acid in 3T3-L1 adipocytes, suggesting a plausible mechanism through which hyperuricemia contributes to the pathogenesis of obesity-related cardiovascular diseases.